NCT00219128
- Conditions
- Cardiovascular Diseases, Hypertension, Vascular Diseases
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
Clinical trial condition
Hypertension
Explore clinical trials studying Hypertension. Study availability and eligibility vary by location and protocol.
4,638 public trials
454 recruiting studies
Hypertension trial results
NCT00327587
- Conditions
- Cardiovascular Diseases, Hypertension, Vascular Diseases
- Locations
-
- Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States
NCT00171561
- Conditions
- Albuminuria, Cardiovascular Diseases, Diabetes Mellitus, +16 more
- Locations
-
- Novartis Pharmaceuticals Basel, Switzerland
Completed
SPP100 Dose Finding Study in Japan
NCT00311012
- Conditions
- Cardiovascular Diseases, Hypertension, Vascular Diseases
- Locations
-
- Novartis Pharmaceuticals Tokyo, Japan
NCT01328210
- Conditions
- Cardiovascular Diseases, Glucose Metabolism Disorders, Hyperinsulinism, +6 more
- Locations
-
- Kliniken Essen-Mitte, University Duisburg-Essen Essen, North-Rhine Westfalia, Germany
NCT00171327
- Conditions
- Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
- Locations
-
- Novartis Moscow, Russia
Completed
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
NCT00171535
- Conditions
- Cardiovascular Diseases, Hypertension, Vascular Diseases
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
Completed
A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
NCT00241007
- Conditions
- Cardiovascular Diseases, Hypertension, Vascular Diseases
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
NCT00294710
- Conditions
- Cardiovascular Diseases, Hypertension, Vascular Diseases
- Locations
-
- Novartis East Hanover, New Jersey, United States
- Investigative Centers, Germany
NCT00219154
- Conditions
- Cardiovascular Diseases, Hypertension, Vascular Diseases
- Locations
-
- Investigative Centers, Germany
- Novartis Pharmaceuticals Basel, Switzerland